首页 › 基金 › Rock Springs Capital Management LP › TARS
Rock Springs Capital Management LP 对 TARS 的持仓历史
TARSUS PHARMACEUTICALS INC · 医疗保健
Rock Springs Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 TARS(TARSUS PHARMACEUTICALS INC)285,122 股,市值约 US$22.4M,约占其申报组合的 1.21%,在其申报持仓中市值排名第 20 位。 Rock Springs Capital Management LP 最近 8 个申报季度中有 8 个季度披露了 TARS 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Rock Springs Capital Management LP 对 TARS 的持仓演变
Rock Springs Capital Management LP 于 Q4 2024 首次披露 TARS 持仓:110,889 股(约 US$6.1M)。 该持仓在 Q3 2026 达到峰值 285,122 股,市值约 US$22.4M。 在 8 次申报中,Rock Springs Capital Management LP 4 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 285,122 股、市值约 US$22.4M,环比增持 8,035 股。。 持仓曾出现大幅变动:Q1 2025 增持约 220% (随后一个季度股价下跌 21%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 110.89K | $6.14M | 新进 |
| Q1 2025 | 354.38K | $18.20M | 增持 |
| Q2 2025 | 373.75K | $15.14M | 增持 |
| Q3 2025 | 288.34K | $17.14M | 减持 |
| Q4 2025 | 260.34K | $21.32M | 减持 |
| Q1 2026 | 225.18K | $15.80M | 减持 |
| Q2 2026 | 277.09K | $17.44M | 增持 |
| Q3 2026 | 285.12K | $22.41M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TARS 与 13F 数据
TARS(TARSUS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 TARS,申报仓位最大的包括:Deep Track Capital, LP (US$299.3M), RTW INVESTMENTS, LP (US$273.9M), Paradigm Biocapital Advisors LP (US$180.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TARS 的基金
- Deep Track Capital, LP 3.81M 股 · $299.25M · Q3 2026
- RTW INVESTMENTS, LP 3.48M 股 · $273.88M · Q3 2026
- Paradigm Biocapital Advisors LP 2.30M 股 · $180.91M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.57M 股 · $98.71M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.10M 股 · $86.17M · Q3 2026
- Vestal Point Capital, LP 1.05M 股 · $66.09M · Q2 2026
- Frazier Life Sciences Management, L.P. 728.64K 股 · $45.86M · Q2 2026
- TCG Crossover Management, LLC 388.16K 股 · $30.51M · Q3 2026
更多关于 Rock Springs Capital Management LP
常见问题
How long has Rock Springs Capital Management LP held TARS?
Rock Springs Capital Management LP has disclosed TARS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Rock Springs Capital Management LP's current position in TARS?
As of Q3 2026, Rock Springs Capital Management LP holds 285.12K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $22.41M, representing 1.21% of its reported portfolio and ranking #20.
Has Rock Springs Capital Management LP been buying or selling TARS?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in TARS. The position peaked in Q3 2026 at 285.12K shares.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.